| | | Single nucleotide variant (3 prime UTR variant) | Hereditary cancer-predisposing syndrome +2 more | GConflicting classifications of pathogenicity |
| | | Single nucleotide variant (missense variant) | Breast and/or ovarian cancer +4 more | GConflicting classifications of pathogenicity |
| | | Single nucleotide variant (missense variant) | CHEK2-Related Cancer Susceptibility +8 more | GConflicting classifications of pathogenicity |
| | | Single nucleotide variant (splice donor variant) | Hereditary cancer-predisposing syndrome +1 more | GPathogenic/Likely pathogenic |
| | | Single nucleotide variant (missense variant) | Hereditary cancer-predisposing syndrome +2 more | |
| | | Single nucleotide variant (missense variant +1 more) | CHEK2-related condition +5 more | |
| | | Single nucleotide variant (missense variant) | Malignant tumor of prostate +9 more | |
| | | Single nucleotide variant (intron variant) | Hereditary cancer-predisposing syndrome +1 more | GConflicting classifications of pathogenicity |
| | | Single nucleotide variant (intron variant) | Hereditary breast ovarian cancer syndrome | |
| | | Single nucleotide variant (missense variant +2 more) | CHEK2-Related Cancer Susceptibility +9 more | GConflicting classifications of pathogenicity |
| | | Single nucleotide variant (intron variant) | not specified | |
| | | Single nucleotide variant (splice donor variant) | not provided +2 more | GPathogenic/Likely pathogenic |
| | | Single nucleotide variant (intron variant) | CHEK2-related condition +7 more | GConflicting classifications of pathogenicity |
| | | Single nucleotide variant (missense variant +1 more) | not specified +2 more | |